Traumatic spinal cord injury (SCI) is a serious neurologic disorder that can result in long-term motor and sensory ...
Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...
Dr. David Nathanson is a professor of molecular and medical pharmacology at UCLA. He received his Ph.D. in molecular and medical pharmacology at UCLA under Dr. Paul Mischel, where he discovered that ...
The principle of pretargeted radioimmunoimaging and therapy has been investigated over the past 30 y in preclinical and clinical settings with the aim of reducing the radiation burden of healthy ...
A new era of precision diagnostics and therapy for patients with neuroendocrine neoplasms began with the approval of somatostatin receptor (SSTR) radiopharmaceuticals for PET imaging followed by ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Johannes Czernin, MD, editor in chief of The Journal of Nuclear Medicine, talked with David W. Townsend, PhD, and Thomas Beyer, PhD, MBA, about their pioneering work in the development of PET/CT ...
Journal of Nuclear Medicine January 2026, jnumed.125.271410; DOI: https://doi.org/10.2967/jnumed.125.271410 ...
WHY IS FAP-TARGETED THERAPY ATTRACTIVE? FAP-positive CAFs are found in more than 90% of epithelial cancers, therefore representing a potential pan-cancer target (6). Targeting FAP to deplete stromal ...
Journal of Nuclear Medicine January 2026, jnumed.125.271020; DOI: https://doi.org/10.2967/jnumed.125.271020 ...
The endogenous μ-opioid receptor (MOR) system plays a key role in the mammalian reward circuit. Human and animal experiments suggest the involvement of MORs in human sexual pleasure, yet this ...
The aim of this work was to develop a theranostic method that allows prediction of prostate-specific membrane antigen (PSMA)–positive tumor volume after radioligand therapy (RLT) based on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results